http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Boston Scientific Announces Agreement to Acquire Silk Road Medical, Inc.
-
Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUS
-
Advancing Healthcare Access: Genesis MedTech Teams Up with Silk Road Medical to Serve Patients affected by Carotid Artery Disease in China
-
Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System
-
Silk Road Medical to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
-
Silk Road Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Silk Road Medical Reports Third Quarter 2023 Financial Results
-
Silk Road Medical (SILK) Appoints Chas McKhann as CEO
-
Silk Road Medical Names Chas McKhann Chief Executive Officer
-
Silk Road Medical to Report Third Quarter 2023 Financial Results on November 8, 2023
-
Silk Road Medical Inc. (SILK) Prelim. Q3 Revenue Misses Consensus
-
Silk Road Medical (SILK) Announces CEO Retirement
-
Silk Road Medical Announces Retirement of CEO Erica Rogers
-
Silk Road Medical Announces Preliminary Third Quarter 2023 Revenue and Provides Revised 2023 Outlook
-
Silk Road Medical to Present at the CL King 21st Annual Best Ideas Conference
-
Silk Road Medical to Present at the UBS MedTech, Tools and Genomics Summit
-
Silk Road Medical Reports Second Quarter 2023 Financial Results
-
Silk Road Medical to Report Second Quarter 2023 Financial Results on August 1, 2023
-
Silk Road Medical Reports First Quarter 2023 Financial Results
-
Silk Road Medical Receives 2023 Great Place To Work Certification™
-
Silk Road Medical Announces Investor Education Webcast with Key Opinion Leaders
-
Silk Road Medical to Present at the BofA Securities 2023 Healthcare Conference
-
Silk Road Medical to Present at the BofA Securities 2023 Healthcare Conference
-
Silk Road Medical to Report First Quarter 2023 Financial Results on May 9, 2023
-
Silk Road Medical to Report First Quarter 2023 Financial Results on May 9, 2023
-
Silk Road Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Outlook
-
Silk Road Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Outlook
-
Silk Road Medical to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
-
Silk Road Medical to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
-
Silk Road Medical to Present at the 41st Annual J.P. Morgan Healthcare Conference
-
Silk Road Medical to Present at the 41st Annual J.P. Morgan Healthcare Conference
-
Silk Road Medical Reports Third Quarter 2022 Financial Results
-
Silk Road Medical Reports Third Quarter 2022 Financial Results
-
Silk Road Medical to Present at Upcoming Investor Conferences
-
Silk Road Medical to Present at Upcoming Investor Conferences
-
Silk Road Medical to Report Third Quarter 2022 Financial Results on November 8, 2022
-
Silk Road Medical to Report Third Quarter 2022 Financial Results on November 8, 2022
-
Silk Road Medical (SILK) Prices 2.33M Share Offering at $43/sh
-
Silk Road Medical Announces Pricing of Public Offering
-
Silk Road Medical Announces Pricing of Public Offering
-
Silk Road Medical Announces Certain Preliminary Financial Data For Quarter Ended September 30, 2022
-
Silk Road Medical Announces Certain Preliminary Financial Data For Quarter Ended September 30, 2022
-
Silk Road Medical (SILK) Announces $100M Proposed Public Offering of Common Stock
-
Silk Road Medical Announces Proposed Public Offering of Common Stock
-
Silk Road Medical Announces Proposed Public Offering of Common Stock
-
Silk Road Medical Announces First Patient Enrolled in ROADSTER 3 Post Approval Study Evaluating TCAR® System in the Treatment of Standard Surgical Risk Patients
-
Silk Road Medical Announces First Patient Enrolled in ROADSTER 3 Post Approval Study Evaluating TCAR® System in the Treatment of Standard Surgical Risk Patients
-
Silk Road Medical to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
-
Silk Road Medical to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
-
Silk Road Medical Reports Second Quarter 2022 Financial Results

